GE HealthCare Technologies (NASDAQ:GEHC) Issues FY 2024 Earnings Guidance

GE HealthCare Technologies (NASDAQ:GEHC) updated its FY 2024 earnings guidance on Tuesday. The company provided EPS guidance of 4.200-4.350 for the period, compared to the consensus EPS estimate of 4.300. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. UBS Group upgraded shares of GE HealthCare Technologies from a sell rating to a neutral rating and lifted their price target for the company from $66.00 to $88.00 in a research report on Monday, February 12th. Citigroup lifted their price target on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a buy rating in a research report on Wednesday, April 3rd. Morgan Stanley lifted their price target on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an equal weight rating in a research report on Monday, February 12th. HSBC assumed coverage on shares of GE HealthCare Technologies in a research report on Thursday, February 15th. They set a buy rating and a $100.00 price target for the company. Finally, Evercore ISI lifted their price target on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an outperform rating in a research report on Thursday, April 4th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of Moderate Buy and an average price target of $95.09.

GE HealthCare Technologies Trading Up 3.1 %

NASDAQ GEHC opened at $88.94 on Tuesday. The firm has a 50 day simple moving average of $88.98 and a 200-day simple moving average of $78.75. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. GE HealthCare Technologies has a one year low of $62.35 and a one year high of $94.50. The firm has a market cap of $40.59 billion, a price-to-earnings ratio of 29.45, a PEG ratio of 3.00 and a beta of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $1.18 EPS for the quarter, beating the consensus estimate of $1.07 by $0.11. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. During the same quarter last year, the firm posted $1.31 earnings per share. The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. Equities research analysts anticipate that GE HealthCare Technologies will post 4.3 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio is currently 3.97%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.